Lilly offers investors safety and growth.

Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.

In the latest trading session, Eli Lilly (LLY) closed at $1,200.06, marking a -1.14% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.72% for the day.

Johnson & Johnson doesn't need GLP-1 drugs to grow, and that's good news for long-term investors.

Before the share price caught on, the drugmaker was dealing with a problem most companies only dream of, and it was the ...

Getting to a $2 trillion market cap from Eli Lilly’s current levels would require a compound annual growth rate of about 11.7% over the next seven years. That’s no easy feat, but if Eli Lilly can pull ...

LCCC is launching a hands-on training pipeline that places technicians directly into the pharmaceutical industry.

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q1 2026 investor letter. A copy of the letter can be ...

After talking to Eli Willits, it is easy to see why he is having all this success. I gained insights into his mentality ...

Let's get to the bottom of the intense ending of Eli on Netflix, shall we? Warning: This post contains major spoilers for Netflix's Eli. When Eli's parents take the young boy to a "clean house" run by ...